Atorvastatin Therapy on Xanthoma in Alagille Syndrome
NCT05488067 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2026-03-27
Summary
To observe the efficacy and safety of atorvastatin on xanthoma in Alagille syndrome through a prospective study.
Conditions
- Alagille Syndrome
- Atorvastatin
- Xanthoma
Interventions
- DRUG
-
Oral atorvastatin treatment for ALGS children with xanthoma
Sponsors & Collaborators
-
Children's Hospital of Fudan University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-22
- Primary Completion
- 2024-08-01
- Completion
- 2024-08-01
Countries
- China
Study Locations
More Related Trials
-
Atorvastatin Effects On Arterial Stiffness In Hemodialysis
NCT04472637 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
NCT05912686 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction
NCT01997294 ·Status: UNKNOWN ·Phase: NA
-
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
NCT02022293 ·Status: SUSPENDED ·Phase: PHASE2
-
Efficacy of Atorvastatin in Chronic Subdural Haematoma
NCT03956368 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis
NCT00811330 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
NCT00585611 ·Status: TERMINATED ·Phase: NA
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
Statin Treatment for UnruptureD Intracranial anEurysms Study
NCT04149483 ·Status: UNKNOWN ·Phase: PHASE2
-
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
NCT01761656 ·Status: UNKNOWN ·Phase: PHASE2
-
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
NCT00920101 ·Status: UNKNOWN ·Phase: PHASE4
-
Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
NCT01086020 ·Status: UNKNOWN ·Phase: PHASE4
-
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
NCT01040936 ·Status: UNKNOWN ·Phase: PHASE4
-
Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting
NCT02565615 ·Status: COMPLETED
-
The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
NCT01015144 ·Status: COMPLETED
-
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
NCT06922994 ·Status: RECRUITING ·Phase: PHASE2
-
Ezetimibe and Atorvastatin Therapy on TCFA
NCT02588235 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes
NCT00520585 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart
NCT00317967 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
NCT00770575 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose of Atorvastatin and Circulating Endothelial Microparticles
NCT02023892 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
NCT00640744 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
NCT01732718 ·Status: COMPLETED ·Phase: PHASE2
-
Statin Therapy in Asymptomatic Aortic Stenosis
NCT00176410 ·Status: UNKNOWN ·Phase: PHASE2
-
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
NCT00441597 ·Status: COMPLETED ·Phase: PHASE4